# Baxter Pharmaceuticals India Pvt Ltd, Ahmedabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/baxter-pharmaceuticals-india-pvt-ltd/dc51d849-2ff2-4ad0-bb54-cb013fd2e24d

> Inspection records and compliance data for Baxter Pharmaceuticals India Pvt Ltd in Ahmedabad. 11 FDA inspections on record (3 OAI), 3 Form 483s, last inspected June 27, 2025.

---

## Details

- Name: Baxter Pharmaceuticals India Pvt Ltd
- FEI Number: 3004610460
- Business Operations: API MANUFACTURE, FDF MANUFACTURE
- Address Line 1: Village Vasana Chacharwadi, Taluka Sanand
- City: Ahmedabad
- Country Name: India
- Address: Village Vasana Chacharwadi, Taluka Sanand, Ahmedabad, India
- Country: India

## Related Documents

- [483 - Baxter Pharmaceuticals India Pvt Ltd - 2025-06-27](https://www.keypedia.com/records/483/baxter-pharmaceuticals-india-pvt-ltd/68b3ba63-2f11-4912-8a22-a1dfa76b2843) — source: FDA, date: June 27, 2025
- [FDA Inspection 1280282 - Baxter Pharmaceuticals India Pvt Ltd - 2025-06-27](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceuticals-india-pvt-ltd/c9ba557a-8f12-4507-9e6e-b0238c141295) — source: FDA, date: June 27, 2025
- [483 - Baxter Pharmaceuticals India Pvt Ltd - 2023-01-27](https://www.keypedia.com/records/483/baxter-pharmaceuticals-india-pvt-ltd/25cb0e8f-58f3-4a60-a7e3-bac9f78f52c8) — source: FDA, date: January 27, 2023
- [FDA Inspection 1195842 - Baxter Pharmaceuticals India Pvt Ltd - 2023-01-27](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceuticals-india-pvt-ltd/fc31be04-c1f8-435e-bce6-5fb197082a57) — classification: Official Action Indicated (OAI), source: FDA, date: January 27, 2023
- [483 - Baxter Pharmaceuticals India Pvt Ltd - 2022-05-17](https://www.keypedia.com/records/483/baxter-pharmaceuticals-india-pvt-ltd/fe9fbabc-09a9-4ef2-a20a-d002a0b147cc) — source: FDA, date: May 17, 2022
- FDA Inspection 1169631 - Baxter Pharmaceuticals India Pvt Ltd - 2022-05-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 17, 2022
- [483 - Baxter Pharmaceuticals India Pvt Ltd - 2017-08-04](https://www.keypedia.com/records/483/baxter-pharmaceuticals-india-pvt-ltd/39ff32de-a58e-445e-8df1-f22283913a75) — source: FDA, date: August 4, 2017
- [FDA Inspection 1028732 - Baxter Pharmaceuticals India Pvt Ltd - 2017-08-04](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceuticals-india-pvt-ltd/ce96d7e2-c444-469f-913c-22f716c9bd65) — classification: Official Action Indicated (OAI), source: FDA, date: August 4, 2017
- FDA Inspection 1019107 - Baxter Pharmaceuticals India Pvt Ltd - 2017-05-31 — source: FDA, date: May 31, 2017
- [483 - Baxter Pharmaceuticals India Pvt Ltd - 2016-08-26](https://www.keypedia.com/records/483/baxter-pharmaceuticals-india-pvt-ltd/8d6b285d-5ce8-402f-b886-4fec22c31f44) — source: FDA, date: August 26, 2016
- FDA Inspection 986348 - Baxter Pharmaceuticals India Pvt Ltd - 2016-08-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2016
- FDA Inspection 929802 - Baxter Pharmaceuticals India Pvt Ltd - 2015-05-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 11, 2015
- FDA Inspection 853758 - Baxter Pharmaceuticals India Pvt Ltd - 2013-10-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 18, 2013
- FDA Inspection 771062 - Baxter Pharmaceuticals India Pvt Ltd - 2012-03-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 2, 2012
- [FDA Inspection 676775 - Baxter Pharmaceuticals India Pvt Ltd - 2010-06-16](https://www.keypedia.com/records/fda_inspections/baxter-pharmaceuticals-india-pvt-ltd/b081c5d5-d0d4-4f18-86f5-04724c38d345) — classification: Official Action Indicated (OAI), source: FDA, date: June 16, 2010

## Related Companies

- [Lyocontract GmbH](https://www.keypedia.com/companies/lyocontract-gmbh/0c56698a-6a88-4c94-9de9-6e9f5172cf27)
- [ENDO Pharmaceuticals Solutions, Inc.](https://www.keypedia.com/companies/endo-pharmaceuticals-solutions-inc/73c5da1a-04ad-4b56-9fae-f0a1371df51f)
- [Kaysersberg Pharmaceuticals SAS](https://www.keypedia.com/companies/kaysersberg-pharmaceuticals-sas/4f0bba88-dadd-49db-8e17-08165e705377)
- [Steriscience Specialties Private Limited](https://www.keypedia.com/companies/steriscience-specialties-private-limited/f2814c8b-daff-42a4-abe2-59947a5bda3d)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/977203cc-5cbe-49ea-9b42-0b797ade4b5e)
- [Steriscience SP. Z O.O.](https://www.keypedia.com/companies/steriscience-sp-z-oo/a2c32aee-8f5f-4bd3-8cc9-9fdcf970ebf4)
- [Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)](https://www.keypedia.com/companies/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/02eeb237-fdd8-40a0-b45c-d4d88f49eb6c)
- [Ningbo Shuangcheng Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/ningbo-shuangcheng-pharmaceutical-co-ltd/942c1651-ee36-4163-9687-ca694ddc24d2)
- [Patheon Italia S.p.A.](https://www.keypedia.com/companies/patheon-italia-spa/eb421078-fb58-4c48-a8ae-f1c1befb8145)
- [Amneal Oncology Private Limited](https://www.keypedia.com/companies/amneal-oncology-private-limited/f2a5c5fe-c103-4cda-9a5b-c7007f51b4f2)

## Related Officers

- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
- [Angela Glenn](https://www.keypedia.com/people/angela-glenn/5ba5e1e2-883b-42c4-aae0-3564820723e8)
- [Thomas J. Arista](https://www.keypedia.com/people/thomas-j-arista/37905892-3285-4f3f-b4b5-f963df1e59d3)
- [Biologist at CBER](https://www.keypedia.com/people/massoud-motamed/a8b363de-eb95-4bd3-8c05-9c34bbdbdc8a)
- [Drug Cadre](https://www.keypedia.com/people/drug-cadre/3c9d24f9-082f-4d39-8796-e32693cf6d4b)
